Retinoid X receptor-α (RXRα) is a kind of nuclear receptor and is a target of cancer prevention and treatment in various types of cancers. Cancer stem cells (CSCs) are regarded as the main cause of carcinoma metastasis, tumor recurrence and chemotherapy resistance. So far, the mechanism how RXRα regulates CSCs remains unknown. In the present study, we found that RXRα was upregulated in head and neck squamous cell carcinoma (HNSCC) tissues and the enriched HNSCC CSCs. Overexpression of RXRα was able to expand the CSC-like properties in HNSCC cells, whereas knockdown of RXRα could repress the stemness respectively. Meanwhile, low doses of cisplatin (CDDP) increased the CSC-like properties and RXRα expression in HNSCC cells. Also, Wnt signaling pathway played a significant role in CDDP-induced CSCs. Simultaneously, curcumin, a plant polyphenol, which is an effective anticancer compound, exhibited an inhibitory effect in the HNSCC CSCs induced by CDDP in vitro and in vivo. Via inhibition of RXRα, curcumin suppressed CSC-like phenotypes induced by CDDP. These findings may suggest a novel mechanism for HNSCC treatment.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one of the predominant types of human cancer (1) and is the sixth leading cause of cancer-related casualties worldwide (2) . Traditional treatment protocols including surgery, radiation therapy and concomitant chemotherapy are approved in treating HNSCC (3) . Most of the HNSCC patients survive for less than 5 years after diagnosis due to local recurrence or metastasis of the primary malignant carcinoma, although many advances have been made in surgery, pharmacology and radiation treatments (3) .
Retinoid X receptor (RXR) is a unique subfamily of the nuclear receptor superfamily encoded by three distinct genes: RXRα, RXRβ and RXRγ. RXRα is a significant regulator of physiological processes such as embryonic development, cellular differentiation, apoptosis, proliferation and organ homeostasis (4, 5) . It can exert significant roles as transcriptional activators and repressors in these biological processes (6) . In response to endotoxin or other inflammatory mediators, RXRα can migrate from the nucleus to the cytoplasm in order to inhibit its transactivation function (7) . For example, RXRα can regulate Nur77/ TR3-dependent apoptosis through mediating its nuclear export and targeting mitochondria (8) . RXRα undergoes rapid nuclear export in response to pro-inflammatory cytokine interleukin1beta (IL-1β) signals (9) . In addition, many studies have revealed the roles of RXRα in several types of cancers (10) (11) (12) . In gastric carcinoma, IL-1β can upregulate RXRα through activation of nuclear factor-κB signaling (10) . For another, RXRα promotes human cholangiocarcinoma growth through nuclear factor-κB pathways activations (11) . During laryngeal carcinogenesis, RXRα upregulation is observed from the early stages of laryngeal carcinogenesis compared with the normal epithelium (12) . In addition, overexpression of RXRα is prevalent in human tumors such as lung cancer and breast cancer (13) . Dual targeting of RXR and histone deacetylase with DW22 can serve as a novel antitumor approach in lung cancer and breast cancer (13) . A high-risk lesion for invasive breast ductal cancer exhibits frequent upregulation of RXRs and RXRα is implicated to be the predominant overexpressed form (14) . Therefore, RXRα has been recognized as a drug target in the treatment of multiple cancers (15) .
The existence of self-renewing, stem-like cells, called cancer stem cells (CSCs) is employed to state the characteristics of neoplastic tissues (16) . CSCs constitute a small portion of tumor cells and demonstrate the capacity to renovate new tumors (17) . Meanwhile, CSCs have been recognized in a number of human cancers including HNSCC (18) . In HNSCC, a subpopulation having stem cell characteristics has been isolated and characterized. Targeting the cancer cells exhibiting CSCs-like properties has become an effective way for the carcinoma treatment (19) . Accumulating evidence has proved that Wnt signaling hastens stem cell self-renewal, tumorigenesis and cancer chemoresistance (20) (21) (22) (23) . For instance, in liver CSCs, Wnt/β-catenin target genes promote the proliferation and invasion (21) . Inhibition of Wnt pathway can prevent the self-renewal and metastasis in breast CSCs (22) . In vivo, blocking Wnt pathway prevents human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model (23) . According to several reports, chemotherapy can enrich CSCs in several types of tumor such as lung cancer (24) , gastric cancer (25) and breast cancer (26) . The stemness properties help tumors to resist to chemotherapy agents. It has been reported that in non-small cell lung cancer, cisplatin (CDDP) treatment can increase stemness through upregulating hypoxia-inducible factors by . CDDP can promote CSC-like properties via the miR-124/IL-6R/STAT3 in gastric cancer (25) . In breast cancer cells, long-term trastuzumab treatment generates highly enriched CSCs (26) . Oxaliplatin and docetaxel can induce a few stem cell characteristics in human colorectal cancer HT29 and HCT116 cells (27) .
However, the mechanism of CSC-like properties triggered by CDDP in HNSCC remains poorly understood and the role RXRα plays in CSCs is unclear. Our findings uncover that RXRα plays an oncogenic role in CDDP-induced CSCs in HNSCC, in which Wnt signaling pathway is activated. We also find that curcumin can act as an adjuvant to combat CDDP-induced CSCs. Our study suggests the possibility of developing CSCs-targeting agents for HNSCC treatment.
Materials and methods

Cell culture and reagents
Hep2 cells and FaDu cells were cultured in Dulbecco's Modified Eagle's Medium (GIBCO, Carlsbad, CA). The medium was supplemented with 10% heat-inactivated fetal bovine serum (GIBCO), 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were cultured in an incubator with 5% CO 2 at 37°C. HNSCC cell lines, Hep2 cells and FaDu cells, were obtained from the Chinese Academy of Sciences Committee on Type Culture Collection Cell Bank (Shanghai, China). All cell lines were used in less than 6 months of continuous passage after acquisition and the LookOut Mycoplasma PCR Detection Kit (Sigma-Aldrich, St. Louis, MO) was employed to test mycoplasma contamination. The cells were authenticated by the cell bank source using short tandem repeat profiling. Curcumin (purity ≥95%) and CDDP (purity ≥99.9%) powders were purchased from Sigma (St. Louis, MO). All other reagents used were in analytically grade or the highest grade available.
Tumor specimens
Eight pairs of HNSCC tissues along with matched adjacent tissues were obtained from patients who received curative resection in the First Affiliated Hospital of Nanjing Medical University. Institutional approval was acquired from the review boards of Nanjing Medical University prior to this study. Before tissue acquisition, we obtained written informed consent from each patient. Institutional approval was obtained from the Ethical Review Board of Nanjing Medical University (Nanjing, China) firstly. Experiment was carried out according to the approved guidelines.
Western blot analysis
Proteins were harvested from Hep2, FaDu cells and HNSCC tissue samples. The samples were lysed in radio immunoprecipitation assay buffer supplemented with PMSF (phenylmethanesulfonylfluoride, protease and phosphatase inhibitors). Bicinchoninic acid protein assay was used for quantification. Proteins were separated on 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (Invitrogen, Carlsbad, CA) first and then transferred onto nitrocellulose filter membranes). Membranes were incubated with primary antibodies for a whole night at 4°C, after blocking in 5% defatted milk. Next day, before incubation with horse radish peroxidase-conjugated secondary antibodies for 1 h at room temperature, the membranes were washed using tris-buffered saline with tween 20. Primary antibodies were as followed: anti-RXRα, anti-CD133, anti-CD44, anti-Sox2, anti-Nanog, anti-Oct4, anti-GSK3β，anti-pGSK3β, anti-β-catenin, anti-p-β-catenin, anti-CyclinD1 (1:1000, Abcam, Cambridge, Britain), anti-β-actin and anti-glyceraldehyde 3-phosphate dehydrogenase (1:1000, BOSTER, Wuhan, China). Secondary antibodies included: Horse Radish PeroxidaseConjugated AffiniPure Goat Anti-Rabbit Immunoglobulin G (IgG) and Horse Radish Peroxidase-Conjugated AffiniPure Goat Anti-Mouse IgG (1:2000, ZSGB-BIO, Beijing, China). Immunoreactive proteins were detected by Chemiluminesence western blotting reagents (Cell Signaling Technology, Danvers, MA). Protein bands were measured using Eagle Eye II software.
Quantitative reverse transcription-polymerase chain reaction
Total RNA was extracted using RNAiso Plus (TaKaRaBio Technology, Dalian, China). RNA was reverse transcribed by the Prime Script TM RT Master Mix (TaKaRa Bio Technology) and quantitative polymerase chain reaction (qPCR) was performed using SYBR Premix Ex Taq II (TaKaRaBio Technology). Quantitative reverse transcription-PCR primers were provided in Supplementary Table S1A and B, available at Carcinogenesis Online. Glyceraldehyde 3-phosphate dehydrogenase was used as an internal mRNA control. qPCR was carried out using the Applied Biosystems 7900 Real Time PCR System (Applied Biosystems, Foster City, CA). The fold change was calculated by the equation 2 -△△ Ct . Relative mRNA levels in tumor tissues were measured using 2 -△ Ct .
Sphere formation assay
Cells were indicated with 10 ng/mL of human recombinant basic fibroblast growth factor (R&D Systems, Minneapolis, MN) and 20 ng/mL of epidermal growth factor (R&D Systems) in serum-free Dulbecco's Modified Eagle's Medium-F12 (Gibco) medium. Cells were fed every 48 h and grown for 10 days. Spheres were observed using a microscope (Olympus, Tokyo, Japan).
Flow cytometry analysis
For side population (SP) analysis, after digested with trypsin and washed with phosphate-buffered saline, cells were then re-suspended 
In vivo xenograft experiments
Twenty-five mice (BALB/c, nude, female, aged 4 wk, weighed 16-18 g) were purchased from Shanghai Animal Laboratory Center. They were fed in appropriate sterile filter-capped cages in the Experimental Animal Center at Nanjing Medical University. Mice were injected subcutaneously in the front dorsum with exponentially growing Hep2 cells (5 × 10 6 each). Tumor lengths and widths were measured by calipers. Volumes were calculated as the following formula: volume (mm 3 ) = length × width × width/2. At 1 wk post transplantation, average tumor volume was about 100 mm 3 . The xenografts were randomized into four groups (six control mice, six mice in the Curcumin group, six in the CDDP group and seven in the combination group). Treatment methods were as follows: control (0.5% carboxymethylcellulose sodium), Curcumin (40 mg/kg), CDDP (5 mg/kg) and Curcumin (40 mg/kg) with CDDP (5 mg/kg). Drugs were given through intraperitoneal injection every 3 days. Body weights and tumor sizes were recorded three times a week. After 2 wk of treatment, all mice were euthanized by cervical dislocation. This study was carried out under the instructions of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health strictly. The protocol was approved by the Committee on the Ethics of Animal Experiments of Nanjing Medical University.
Statistical analysis
All data were presented as the mean ± standard deviation (SD) of at least three independent experiments. Comparisons between quantitative variables were assessed using the student's t-test and one-way analysis of variance. Data were considered statistically significant when P < 0.05. SPSS 17.0 (SPSS, Chicago, IL) and GraphPad Prism v5.0 (Graphpad Software) software was used for statistical analysis.
Results
RXRα was upregulated in HNSCC tumor tissues and CSC-enriched HNSCC cells
It has been well established that altered expression and abnormal function of RXRα are involved in various tumors (10) (11) (12) . Nevertheless, the function of RXRα in regulating tumorigenesis in HNSCC is poorly understood. In our current study, the aberrant expression of RXRα was first investigated in HNSCC tissues. The stage and clinical characteristics of the HNSCC patients were exhibited in Supplementary Table S2 , available at Carcinogenesis Online. As exhibited in Figure 1A and 1B, RXRα in tumor tissues was significantly upregulated in both mRNA and protein levels compared with the peritumor tissues. Next, we used serum-free suspension culture to obtain cancer stem-like cells from HNSCC Hep2 and FaDu cells. The spheroid morphology was observed in Hep2 ( Figure 1C ) and FaDu cells ( Figure 1E ). Sox2, Nanog and Oct4 are important transcription factors maintaining the CSC phenotypes in many kinds of cancer (28) . To verify the CSC-like properties of the acquired spheroids, Sox2, Nanog and Oct4 mRNA and protein levels were detected by qPCR analysis and western blot tests. As shown in Figure 1D and F, the mRNA expression of Sox2, Nanog and Oct4 was greatly over-expressed in the spheroids of Hep2 and FaDu cells in comparison to the parental Hep2 and FaDu cells. Consistently, the protein levels of Sox2, Nanog and Oct4 were upregulated as well ( Figure 1H ). Interestingly, in Figure 1G and H, the overexpressed RXRα was observed in HNSCC cells with CSC-like properties. All these results indicated that RXRα was associated with CSCs in HNSCC.
RXRα was responsible for the enriched CSC-like properties in HNSCC cells
To validate the hypothesis above, the human RXRα plasmid pECE-RXRα or the control plasmid pECE was transfected into Hep2 cells. Herein, the RXRα expression was dramatically increased as demonstrated in Figure 2A . Then pECE-RXRα was transfected into CSC-enriched HNSCC cells and we observed that compared to the vectors transfection, the spheroid volume of Hep2 cells became larger ( Figure 2B ). As CD133 and CD44 are two important CSC surface markers in several types of cancer (28) , overexpression of RXRα could markedly increase CD133, CD44, Sox2 and Oct4 mRNA expression and protein levels ( Figure 2C and D) in HNSCC cells. Aside from the stemness biomarkers, we also tested copper transporter 1 (CTR1) protein expression. According to many studies, CTR1 can be recognized as an important chemoresistance indicator, especially for CDDP resistance (29) . It was observed that RXRα overexpression dramatically decreased CTR1 protein expression ( Figure 2D ). SP cells are identified to contain putative CSCs and have the ability to pump out Hoechst 33342 (30) . In consequence, SP test by flow cytometry was employed in our research to measure the CSCs ratios. SP cell ratios were obviously elevated by transfection of RXR plasmids ( Figure 2E ). In addition, Figure 2F showed that single staining of CD44 surface markers exhibited higher levels as well. Since 9-Cis-RA is identified as agonist of RXRα, we investigated whether activation of RXRα can affect CSC-like properties of HNSCC cells. Figure 2G demonstrated that CD133, CD44 and Sox2 were increased by the indicated doses of 9-Cis-RA. Meanwhile, the percentage of CD44 + cells was increased by 9-Cis-RA in a dose-dependent manner ( Figure 2H ). These results suggested that RXRα overexpression and activation were able to expand the CSC-like properties in HNSCC cells.
Knockdown and inactivation of RXRα alleviated the stemness in HNSCC cells
For another, to evaluate the effect of decreased RXRα on stemness in HNSCC cells, RXRα siRNA or siRNA control was transfected into Hep2 cells. First, we observed that RXRα was decreased obviously upon the siRNA transfection ( Figure 3A) . Next, RXRα siRNA was transfected into CSC-enriched HNSCC cells and we found that knockdown of RXRα inhibited the spheroid volume significantly ( Figure 3B ). Then, RXRα siRNA was transfected into the parental cells and we observed that CSC markers expression such as CD133, CD44, Sox2 and Oct4 was suppressed ( Figure 3C and D) . In Figure 3D , it was exhibited that RXRα knockdown can greatly elevate CTR1 protein expression in HNSCC cells.In addition, the ratios of SP and CD44 + cells were restrained by RXRα siRNA (Figure 3E and F) . UVI3003 as RXRα antagonist can decrease CD133, CD44 and Sox2 protein levels and the ratios of CD44 + cells dose-dependently ( Figure 3G and  H) . On the basis of these results, it was suggested that RXRα 
CDDP induced CSC-like properties in HNSCC cells
CSCs are related to chemotherapy efficacy, and CDDP can increase stemness in multiple cancers (24) (25) (26) (27) . In Figure 4A , HNSCC CSCs were obtained by serum-free suspension culture first and then treated with different doses of CDDP for 24 h. Low doses of CDDP could expand the spheroid volume in Hep2 and FaDu cells. Besides this, we found that CDDP could elevate RXRα protein levels and reduce CTR1 protein expression dramatically ( Figure 4B ). Wnt signaling pathway is involved in the maintenance of stemness in many kinds of cancers (20) (21) (22) (23) . Since GSK3β and CyclinD1 are commonly regarded as Wnt-associated genes, we found that CyclinD1 was increased and GSK3β was decreased 
Curcumin suppressed stemness induced by CDDP via inhibition of RXRα in vitro
It is well known that natural compounds such as curcumin have the ability to inhibit CSC-like properties in multiple tumor types (31, 32) . Hep2 and FaDu cells were incubated with different doses of curcumin for 24 h. Intriguingly, the RXRα expression was repressed by curcumin incubation significantly and curcumin can upregulate CTR1 protein levels respectively ( Figure 5A and B) . Figure 5C -F demonstrated that 10 μM curcumin could inhibit the expression of RXRα and CSC markers including Sox2, Nanog and Oct4 induced by 2 μM CDDP. Moreover, curcumin reversed the CDDP-increased CD44 + and SP cell ratios in Hep2 and FaDu cells ( Figure 5G and H) . Collectively, these results presented that curcumin was able to restrain stemness triggered by CDDP through inhibition of RXRα in HNSCC. To investigate the correlation between RXRα and Wnt/β-catenin activity in tumor pathogenesis, we tested RXRα levels and canonical Wnt activity in Hep2 cells. When Hep2 cells were transfected with RXRα plasmids, we found that Wnt signaling pathway was activated ( Figure 6A ) and the downstream genes including CyclinD1, Tcf1, Axin2, Lef1 and Twist1 were increased greatly ( Figure 6B ). However, when RXRα was inhibited ( Figure 6C ), Wnt signaling pathway was inactivated and the downstream genes expressions were decreased as shown in Figure 6D . These results indicated that CSC-like properties induced by RXRα might be dependent on Wnt signaling pathway in Hep2 cells.
Curcumin suppressed CSC-like phenotypes induced by CDDP via inhibition of RXRα in vivo
A Hep2 cells nude mouse xenograft model was established to determine whether curcumin suppressed CSC phenotypes induced by CDDP via downregulation of RXRα. All the mice were divided into four groups and tumors were peeled from nude mice subcutis ( Figure 6E ). Both curcumin and CDDP inhibited tumor growth, and combination therapy showed a better inhibitory effect ( Figure 6F ). Meanwhile, curcumin prevented CDDPinduced RXRα and other CSC markers including Sox2, Nanog and Oct4 protein expression, which was consistent with in vitro results ( Figure 6G ). Therefore, these results suggested that curcumin could inhibit stemness triggered by CDDP via inhibition of RXRα in vivo.
Discussion
It has been well identified that cancer cells with CSC-like properties can lead to chemotherapy failure (16). Our study indicated that RXRα was upregulated in HNSCC tissues and the enriched HNSCC CSCs. We observed that RXRα overexpression increased the CSC-like properties in HNSCC cells, whereas knockdown of RXRα decreased the stemness. To our knowledge, it is a first report uncovering a possible mechanism for RXRα-triggered CSC-like properties in HNSCC. Although CSCs still need more specified definition, our progress in HNSCC CSCs has provided a deeper understanding about HNSCC chemoresistance, recurrence and metastasis.
Altered expression and function of RXRα are implicated in the development of a number of cancers (10) (11) (12) . RXRα expression is reported to be elevated in gastric carcinoma (10), human cholangiocarcinoma (11) and laryngeal carcinoma (12) . Paradoxically, compared with adjacent non-tumor tissues, RXRα expression is dramatically inhibited in colorectal cancer (33) , thyroid carcinoma (34) and liver cancer (35) , which suggests that the altered expression of RXRα may be in a cancer type-dependent manner. Besides the altered levels of RXRα protein, phosphorylation and proteolytic cleavage can also change RXRα function. In human hepatocellular carcinoma, phosphorylation of RXRα at serine 260 impairs its metabolism and function (36) . In human colon cancer cells, phosphorylated RXRα is an important target for colon cancer treatment (37) . In addition, proteolytic cleavage of RXRα can lead to production of a truncated product, tRXRa, which promotes cancer cell survival (38) . In the current study, we found that RXRα expression was significantly increased in HNSCC tissues ( Figure 1A and B) and the induced HNSCC CSCs ( Figure 1G and H) . The detailed mechanism of RXRα upregulation in HNSCC remains unclear, and need further investigation. Our present study also focused on the possible mechanisms of RXRα on CSC-like characteristics in HNSCC. We observed that RXRα overexpression increased the CSC markers CD133, CD44, Sox2 and Oct4 and the ratios of SP and CD44 + cells ( Figure 2C-H) . Activation of RXRα can also induce stemness of HNSCC cells. Reversely, knockdown and inactivation of RXRα decreased the CSC-like phenotypes ( Figure 3C-H) . Besides these, RXRα was able to influence chemoresistance of HNSCC cells via modulating CTR1 promote expression. Nevertheless, how RXRα regulates the stemness in HNSCC needs further exploration. Since RXRα can serve as an important transcriptional activator and repressor, whether the protein levels of the CSC markers change upon loss or gain of RXRα in HNSCC is indirect or direct needs further exploration.
CSCs are a subset of cells within tumors that can initiate and maintain malignant tumors (39) . Accumulating evidence proves that induced CSCs can be acquired by chemotherapy and their therapeutic implications. It has been reported that breast CSCs can be sorted by suspension culture combined with chemotherapeutic agents (40) . Because of CSCs, recurrent hepatocellular carcinoma-derived cell lines are resistant to previous chemotherapy drugs (41). 5-Fu or oxaliplatin is able to enrich the CSC markers from chemo-resistant colorectal cells (42) . In addition, CDDP or paclitaxel alone or in combination can lead to a great enrichment of CSCs in ovarian cancer cell lines (43) . CDDP treatment can increase CSC-like phenotypes in non-small cell lung cancer, and IL-6-mediated hypoxia inducible factor-1 upregulation plays an important role in increasing stemness (24) . According to our study, low doses of CDDP could induce stemness in HNSCC cells. Increasing evidence has elaborated the mechanism of acquisition of CSC-like phenotypes in HNSCC. Enhanced chemo-sensitivity can be acquired by downregulating Nanog in HNSCCs (44) . However, the mechanism of enriched CSC-like phenotypes by CDDP in HNSCC remains unclear. It was observed in our current study that the fraction of CSCs in head and neck cancer could be enhanced by CDDP through overexpression of RXRα and decreasing CTR1 protein levels ( Figure 4A and B). We investigated that the ratios of SP and CD44+ cells were increased by CDDP treatment in a dose-dependent manner in HNSCC cells, which suggested that CDDP expanded the proportion of CSCs ( Figure 4C and D) .
Increasing evidence has demonstrated that aberrant activation of signaling pathways, including the Wnt, Hedgehog and Notch pathways, is implicated in modulating CSCs (45) . For instance, NOTCH1 downregulation can target head and neck CSCs and enhance the efficacy of CDDP, docetaxel and 5-fluorouracil (46) . A Hedgehog inhibitor GANT61 exhibits anti-CSC activity in estrogen receptor-positive breast cancer cells (47) . It was investigated in our study that Wnt signaling pathway was activated in RXRα-induced CSC-like properties. It has been previously reported that β-catenin and RXRα can interact with each other in cancer cells. For instance, RXRα can promote human cholangiocarcinoma growth through activation of Wnt/β-catenin and nuclear factor-κB pathways (48) . However, in hepatocellular carcinoma, there is a reciprocal interaction of Wnt and RXRα pathways (49) . Wnt signaling regulates cell cycle progression, apoptosis, proliferation, migration and differentiation. It has been shown that Wnt/β-catenin pathway is aberrantly activated in many types of oncogenic diseases (50) (51) (52) . For example, Wnt signaling pathway has been reported to be highly activated in hepatocellular carcinoma (50) . Aberrant Wnt signaling can contribute to leukemogenesis (51) . In HNSCC, druggable targets in the Wnt signaling pathway could improve the treatment outcome (52) . In our study, we observed that RXRα could activate Wnt signaling pathway ( Figure 6A ) and the downstream genes, including CyclinD1, Tcf1, Axin2, Lef1 and Twist1, were increased significantly ( Figure 6B ). When RXRα was inhibited ( Figure 6C ), Wnt signaling pathway was inactivated and the downstream gene expressions were suppressed ( Figure 6D ). Therefore, according to our study, there was a positive correlation between RXRα and Wnt signaling pathway.
Natural compounds such as curcumin have the ability to inhibit carcinogenesis through inactivating Wnt signaling pathway in multiple tumor types (53, 54) . Curcumin inhibits gastric carcinoma and induces apoptosis by restraining the Wnt/β-catenin signaling pathway (54) . In colon cancer, curcumin can suppress tumor epithelial-mesenchymal transition by inactivating the Wnt signaling pathway (55) . Our current study indicated that curcumin was able to decrease the CDDP-triggered CSC-like properties via inhibition of RXRα and ameliorate CDDP resistance by inducing CTR1 expression. However, despite preclinical activity of curcumin was well-explored in our current study both in vitro and in animal models, positive clinical outcomes with curcumin are warranted in the further research.
In summary, our findings uncover an oncogenic role for RXRα in CDDP-induced CSCs in HNSCC, which depends on Wnt signaling pathway. In addition, our results in HNSCC cells and xenografts model indicate that the use of curcumin as an adjuvant to combat CDDP-induced CSCs. Our study suggests the possibility of developing CSCs-targeting agents for HNSCC chemotherapy and further studies are warranted.
Supplementary material
Supplementary Table S1 can be found at Carcinogenesis online.
